OPTOMYCIN Drug Patent Profile
Which patents cover Optomycin, and what generic alternatives are available?
Optomycin is a drug marketed by Optopics and is included in one NDA.
The generic ingredient in OPTOMYCIN is chloramphenicol. There is one drug master file entry for this compound. Additional details are available on the chloramphenicol profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OPTOMYCIN?
- What are the global sales for OPTOMYCIN?
- What is Average Wholesale Price for OPTOMYCIN?
Summary for OPTOMYCIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Patent Applications: | 3,216 |
| DailyMed Link: | OPTOMYCIN at DailyMed |
US Patents and Regulatory Information for OPTOMYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optopics | OPTOMYCIN | chloramphenicol | SOLUTION/DROPS;OPHTHALMIC | 062171-001 | Mar 31, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
